HYOPTRA

US serial number:85193226
Application filling date:Dec. 08, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Feb. 02, 2015
Publication date:Nov. 01, 2011
Abandoned date:Feb. 02, 2015
Standard character claim:Yes. The mark consists of standard characters without claim to any particular font style, size, or color.
Mark drawing type:4 - STANDARD CHARACTER MARK
Goods and services:For: Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmolo
Current owner owner name:Pfizer Inc.
Current owner owner address:235 East 42nd Street New York, NEW YORK UNITED STATES 10017
Current owner legal entity type:CORPORATION
Current owner state or country:DELAWARE
Attorney name:Katrina Edge
Attorney email:deadlinesipnyo@pfizer.com
Attorney docket number:HYOPTRA/USA
Attorney email authorized:Yes
Correspondent name address:KATRINA EDGE PFIZER INC. 150 E 42ND ST NEW YORK, NEW YORK UNITED STATES 10017-5612
Correspondent phone:212-733-4053
Correspondent email:deadlinesipnyo@pfizer.com
Correspondent fax:212-573-2273
Correspondent email authorized:Yes
Trademark staff tm attorney:BUONGIORNO, CHRISTOPHE
Trademark staff law office assigned HYOPTRA:LAW OFFICE 102

Reviews

Required fields are marked *